Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18116
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Athyros, V. G. | en |
dc.contributor.author | Papageorgiou, A. A. | en |
dc.contributor.author | Elisaf, M. S. | en |
dc.contributor.author | Mikhailidis, D. P. | en |
dc.date.accessioned | 2015-11-24T18:50:38Z | - |
dc.date.available | 2015-11-24T18:50:38Z | - |
dc.identifier.issn | 0300-7995 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18116 | - |
dc.rights | Default Licence | - |
dc.subject | Creatinine/blood | en |
dc.subject | *Diabetes Complications | en |
dc.subject | Diabetes Mellitus/blood | en |
dc.subject | Diabetic Nephropathies | en |
dc.subject | Glomerular Filtration Rate/*drug effects | en |
dc.subject | Humans | en |
dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors/classification/*therapeutic use | en |
dc.subject | Hyperlipidemias/complications/*drug therapy | en |
dc.subject | Risk Factors | en |
dc.title | Statins and renal function in patients with diabetes mellitus | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.1185/030079903125002315 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/14606984 | - |
heal.identifier.secondary | http://informahealthcare.com/doi/abs/10.1185/030079903125002315 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2003 | - |
heal.abstract | Lipids may adversely affect renal function. The recently published MRC/BHF Heart Protection Study (HPS) subgroup analysis showed that simvastatin significantly reduced the fall in glomerular filtration rate in high-risk patients with and without diabetes mellitus. These findings are in line with those of smaller earlier studies, including the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Lipid lowering trials need to consider that changes in renal function may occur. Renal and ischaemic heart disease may progress in parallel and statins may be beneficial to both organs. | en |
heal.journalName | Current Medical Research and Opinion | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License